MIRA
INFORM REPORT
|
Report Date : |
12.06.2007 |
IDENTIFICATION DETAILS
|
Name : |
GLOBAL
MEDICAL SOLUTIONS HONG KONG LTD |
|
|
|
|
Registered Office : |
28FL Coda Designer Centre |
|
|
|
|
Country : |
|
|
|
|
|
Date of Incorporation : |
January 4, 1991 |
|
|
|
|
Com. Reg. No.: |
295802 |
|
|
|
|
Legal Form : |
|
|
|
|
|
Line of Business : |
Trading radio pharmaceuticals for diagnosis and treatment, prostate brachytherapy,
different types of syringe shields, vial shields, lead-line furniture,
imaging accessories and lung ventilation system and accessories. Provides unit doses of diagnostic imaging agents and cancer therapy
agents. |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
Up To USD 25,000 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
name & address
GLOBAL MEDICAL
SOLUTIONS HONG KONG LTD
28FL CODA DESIGNER CENTRE
TEL : 852 25629398
FAX : 852 25629121
EXECUTIVE SUMMARY
INCORPORATION DATE :
JANUARY 4, 1991
REGISTRATION NO. :
295802
CHIEF EXECUTIVE :
MR. KENNETH KWONG (MANAGING DIRECTOR)
STAFF STRENGTH :
15
CAPITAL :
US$ 539,053
BUSINESS LINE :
TRADER
TURNOVER :
N/A (AS OF DEC. 31, 2005)
EQUITIES :
N/A (AS OF DEC. 31, 2005)
PAYMENT :
AVERAGE
RECOMM.
MARKET CONDITION :
AVERAGE
FINANCIAL CONDITION :
FAIRLY STABLE
OPERATIONAL TREND :
STEADY
GENERAL REPUTATION :
AVERAGE
EXCHNAGE RATE :
HKD 7.781425 = US$1 AS OF 2007-6-11
Adopted abbreviations:
ANS - amount not stated
NS - not stated
SC - subject company (the company inquired by you)
NA - not available
M - million
HKD –
*Company Registration*
===================
(1)
License number : 295802
Date issued : 4 January,
1991
Issuing authority : Companies
Registry
Legal form : Private
Company with a share capital
Type of license : National Company
License
(2)
License number : 14287379
Issuing authority : Business
Registration Office - Inland Revenue Dept
Type of license : National
Business License
*Company Name*
=============
Incorporated as : SOLID
CONCEPT LTD
Date of incorporation : 4
January, 1991
Changed name to : SYNCOR HONG
KONG LTD
Date of change : 9 April,
1991
Changed name to : GLOBAL
MEDICAL SOLUTIONS HONG KONG LTD
Date of change : 9
February, 2004
*Registrar*
=========
APF PARTNERS CORPORATE SERVICES
*Capital Details*
=============
Authorized capital : HKD 4,210,000.00 divided into 4,210,000 ordinary
shares at HKD 1.00/-each, fully paid
*Office & Facilities*
================
Comment : Maintains 10,000 clean
rooms and a class 100 dispensing laminar air-flow hood.
Other e-mail : corporateservices@angelawangco.com
*Corporate & Organization Structure*
=============================
The company is operated and managed by an experienced professionals.
*Industry Ranking*
===============
Ranked number two (2) on the US Government's Top 20 Hazardous Substances
Priority List.
*Reputation*
==========
Reference checking for the purpose of establishing the firm's reputation
within the respective industry failed to reveal any negative information.
*Approved Signatures*
===================
Mr. Chung-yin Kwong can sign on behalf of the company with seal affixed.
Website : www.gmshk.com The design is professional and the content
is well organized. At present it is in English version.
E-mail : enquiry@gmshk.com
For the past two years there is no record of litigation.
Direct / Indirect Corporate Parent Details
Direct Parent : GLOBAL MEDICAL SOLUTIONS LTD
Country :
*Major Shareholders*
=================
Total number of shareholders :
2
Total number of ordinary shares : 4,210,000
Shareholders' Name No. of
Ordinary Shares Amount of Shares
(HKD) % of Shares
-------------------------- ------------------------------- --------------------------------- ----------------
GLOBAL MEDICAL SOLUTIONS LTD 4,209,999 4,209,999.00 100.00
Mr. Haig
*Director's Details*
===============
Mr. Haig
Pasport number : 153415292
Address :
*Company Secretary*
=================
APF PARTNERS SECRETARIES LTD
Address : Rm 24A
Entertainment Bldg 30 Queen's Rd
License number : 335332
Name Nationality
Job Description
Mr. Kenneth Kwong
Mr. Kenneth Chung-yin Kwong
Mr. Patrick Wong
*Key Personnel*
=============
(1)
Mr. Kenneth Chung-yin Kwong
National ID no : G438480(5)
Address : 24G
Block 2 Cheerful Garden Siu Sai Wan
Responsibility : Handles the
overall management of the company.
(2)
Mr. Patrick Wong
Email : wongkh@gmshk.com
*Main Products & Services*
======================
Specializes in the following areas of work :
1. Trading radio pharmaceuticals
for diagnosis and treatment, prostate brachytherapy, different types of syringe
shields, vial shields, lead-line furniture, imaging accessories and lung
ventilation system and accessories.
2. Provides unit doses of
diagnostic imaging agents and cancer therapy agents.
Products also include the following :
- Tc-99m Sestamibi (Cardiac, Parathyroid, Breast)
- Tc-99m Filtered/Unfiltered Sulfur Colloid (Liver, Sentinel Node, Bone
Marrow)
- Tc-99m MDP (Bone)
- Tc-99m HDP (Bone)
- Tc-99m PYP (Cardiac, Bone, Blood)
- Tc-99m DTPA (Renal, Lung)
- Tc-99m DMSA (Renal)
- Tc-99m Mebrofenin (Hepatobiliary)
- Tc-99m MAA (Lung, Liver)
- Tc-99m HSA (Blood)
- Tc-99m MAG-3 (Renal)
- Tc-99m Bicisate (Brain)
- Thallium Chloride (Tl-201) and Gallium Citrate (Ga-67) injections
- Iodide (I-131) Capsules (therapy or diagnostic) and Solution
- Y-90 Yttrium Spheres for Liver Cancer
- I-131 Lipiodol for Liver Cancer
- I-131 Iodonorcholestreol
- Samarium (Sm-153) Quadramet
- I-125 seeds for Prostate Cancer
- Mo99/Tc99M Generator
- Diagnostic Iodide (I-131) mIBG
- Erbium Citrate Injectable Suspension (Er-169), for Treatment of
Rheumatoid Arthritis of Small Joints
- Rhenium Injectable Suspension (Re-186) for Treatment of Rheumatoid
Arthritis of Medium Joints
- Yttrium Citrate Injectable Suspension (Y-90) for Treatment of
Rheumatoid Arthritis of Joints
Products : Brachytherapy
Air-cushioned face masks
Diagnostic imaging
Imaging accessories
Lead bricks
*Payment Terms*
=============
Sales
------
Local : Cash or credit
Export : Letter of Credit (L/C)
Telegraphic Transfer
(T/T)
Purchases
--------------
Local : Cash or credit
Import : Letter of Credit (L/C)
Telegraphic Transfer
(T/T)
*Local Distribution Network*
======================
Majority of the annual turnover is attributed to local sales.
*Export Markets*
=============
Part of the annual turnover is attributed to export.
*Overseas Suppliers*
================
Supplier's Name : AUSTRALIAN
RADIO ISOTOPES
Country :
*(Subsidiaries, Joint-ventures & Affiliates)
================================
Company Name : GLOBAL MEDICAL SOLUTIONS LTD
Address :
Country :
Relationship : Affiliate
Legal Form : Private Limited Company
Company Type : Manufacturer
Industry : Medical Equipment & Pharmaceutical
PAYMENT RATING : 3 OBTAINED SCORES : 52
|
Implication |
Implications |
|
|
1 |
Scores 85–100 |
Excellent |
|
2 |
Scores 75 – 84 |
Above Average |
|
3 |
Scores 50 – 74 |
Average |
|
4 |
Scores 35 – 49 |
Fair |
|
5 |
Scores 15 – 34 |
Below Average |
|
6 |
Scores 01 – 14 |
Poor |
|
NR |
No Data |
No Data |
The rating indicates the payment
pattern of SC based upon our Payment Database, comments from suppliers of SC,
information from banks (if available), as well as industrial sources.
Dealings on open terms may be possible for SMALL
amounts depending on individual judgement experience.
*Financials*
=========
As a private limited company there is no legal requirement according to
local corporate law for public disclosure of detailed financials.
*Bank Details*
============
Bank Name : BANK OF
Branch :
Branch Address : 17Fl
SWIFT Code : BOFAHKAX
SC is considered small-sized in its line with favorable market
conditions. It is considered a credit line up to USD 25,000 appears to be within SC’s capacities.
Attached:
trade references
SIC PRODUCT CLASSIFICATION & ACTIVITY
Activity Code Product/Service Description
Service 8071 Medical
Laboratories
Trading 2834 Pharmaceutical
preparations
Trading 3841 Surgical
and medical instruments and apparatus
Trading 5047 Medical/Dental
Equip/Supplies
Trading 5122 Drugs/Druggists'
Sundries
HARMONIZED PRODUCT CLASSIFICATION & ACTIVITY
Activity Code Product/Service Description
Trading 2844400020 Radioactive
elements, isotopes and compounds other than those of subheadings
2844.10,
2844.20, and 2844.30
Trading 3000 Pharmaceutical
products
Trading 3006 Pharmaceutical goods (specified
sterile prod etc.)
Trading 7017905000 Other
laboratory, hygienic or pharmaceutical glassware
Trading 9018310080 Other
syringes, with or without their needles
Trading 9018310090 Parts
and accessories for syringes, with or without their needles
Trading 9022110000 Apparatus
based on the use of x-rays for medical, surgical, dental or veterinary
uses,
including radiography or radiotherapy apparatus
Trading 9402900020 Medical,
surgical, dental or veterinary furniture
Trading 9403806080 Furniture
of other materials
DETAILED PRODUCT CLASSIFICATION & ACTIVITY
Activity Product/Service Description
Trading Lead-lined furniture
Trading Lung ventilation accessories
Trading Lung ventilators
Trading Nuclear medicine
Trading Nuclear medicine shielding
Trading Oncology products
Trading PET unit dose cabinets
Trading Phantoms
Trading Positioning blocks
Trading Prostate brachytherapy
INTERNATIONAL TRADE : ACTIVITY & MARKETS
Exporting to
Exporting to
Exporting to
Exporting to
Exporting to
Exporting to
Exporting to
Exporting to
Importing from
Importing from
Importing from
Importing from
Importing from
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems
comparatively below average/normal. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)